Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection Hani J. MarcusDanyal Z. KhanEdward R. Laws OriginalPaper Open access 06 July 2021 Pages: 839 - 853
Pituitary apoplexy and panhypopituitarism following acute leptospirosis Jaypalsinh GohilArun GowdaPrakash Nair OriginalPaper 21 May 2021 Pages: 854 - 858
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease Takako ArakiJutarat SangtianYasuhiko Kawakami OriginalPaper 26 May 2021 Pages: 859 - 866
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score Mendel Castle-KirszbaumPeter FullerTony Goldschlager OriginalPaper 26 May 2021 Pages: 867 - 877
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI Sven BerkmannMichel RoethlisbergerFreimut Juengling OriginalPaper 21 June 2021 Pages: 878 - 886
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study Susan L. SamsonFeng GuMarek Bolanowski OriginalPaper Open access 18 July 2021 Pages: 887 - 903
Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles Christian HagelUlrich SchüllerWolfgang Saeger OriginalPaper Open access 03 September 2021 Pages: 904 - 913
Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients Filippo CeccatoLaura LizzulCarla Scaroni OriginalPaper Open access 26 June 2021 Pages: 914 - 921
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas Mendel Castle-KirszbaumYi Yuen WangTony Goldschlager OriginalPaper 25 June 2021 Pages: 922 - 929
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients Jai Deep ThakurAlex CorlinDaniel F. Kelly OriginalPaper Open access 02 July 2021 Pages: 930 - 942
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Artak LabadzhyanL B NachtigallC J Strasburger OriginalPaper Open access 25 June 2021 Pages: 943 - 953
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Artak LabadzhyanL B NachtigallC J Strasburger Correction Open access 04 August 2021 Pages: 954 - 954
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas Ji Yong ParkWonsuk ChoiHo-Cheol Kang OriginalPaper 29 June 2021 Pages: 955 - 963
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker? J.-F. BonnevilleL. TshibandaA. Beckers OriginalPaper 12 July 2021 Pages: 964 - 969
Primary sellar melanocytoma M. ClausM. Van Der LindenG. T’Sjoen ReviewPaper 13 September 2021 Pages: 970 - 977
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis Karan J. YagnikDana EricksonJamie J. Van Gompel OriginalPaper 27 September 2021 Pages: 978 - 988